Cargando…

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker

Background: The latest research identified cuproptosis as an entirely new mechanism of cell death. However, as a key regulator in copper-induced cell death, the prognostic and immunotherapeutic value of FDX1 in pan-cancer remains unclear. Methods: Data from the UCSC Xena, GEPIA, and CPTAC were analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chi, Zeng, Yuanxiao, Guo, Xiuchen, Shen, Hangjing, Zhang, Jianhao, Wang, Kaikai, Ji, Mengmeng, Huang, Shengwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388757/ https://www.ncbi.nlm.nih.gov/pubmed/35991547 http://dx.doi.org/10.3389/fgene.2022.923737

Ejemplares similares

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
por: Zhu, HuaXin, et al.
Publicado: (2022)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023)

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
por: Xu, Jiahao, et al.
Publicado: (2022)

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2022)

Prognostic, Clinicopathological, and Function of Key Cuproptosis Regulator FDX1 in Clear Cell Renal Cell Carcinoma
por: Zeng, Song, et al.
Publicado: (2022)

Corrigendum: Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2023)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting
por: Cai, Congbo, et al.
Publicado: (2023)

Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysis
por: Liu, Ziqiang, et al.
Publicado: (2023)

Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
por: Zhao, Yaqi, et al.
Publicado: (2022)

Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer
por: Sun, Lianhui, et al.
Publicado: (2023)

FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis
por: Huang, Xing, et al.
Publicado: (2022)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)
por: Wang, Lizong, et al.
Publicado: (2022)

Cuproptosis patterns and tumor microenvironment in endometrial cancer
por: Chen, Junfeng, et al.
Publicado: (2022)

A Novel Cuproptosis-Related Prognostic Model and the Hub Gene FDX1 Predict the Prognosis and Correlate with Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Kenan, et al.
Publicado: (2022)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer
por: Yun, Yuhui, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
por: Wu, Zhaoping, et al.
Publicado: (2023)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis
por: Zhang, Shun, et al.
Publicado: (2022)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

Crystal structure and biochemical characterization of Chlamydomonas FDX2 reveal two residues that, when mutated, partially confer FDX2 the redox potential and catalytic properties of FDX1
por: Boehm, Marko, et al.
Publicado: (2015)

Pan-cancer analyses reveal IGSF10 as an immunological and prognostic biomarker
por: Zhou, Yongxia, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC
por: Qin, Haotian, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC
por: Wu, Lei, et al.
Publicado: (2023)

Risk model of hepatocellular carcinoma based on cuproptosis-related genes
por: Liu, Zhiqiang, et al.
Publicado: (2022)

The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses
por: Xu, Chenyang, et al.
Publicado: (2022)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
por: Hou, Dong, et al.
Publicado: (2022)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment
por: Xie, Mingyue, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Gao, Shuang, et al.
Publicado: (2021)

A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
por: Liu, Xin, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6t7hm0u6bakbpe3ttfp3cmiis1